shutterstock_1368438578

cell culture equipment.

In recent decades, the biotech market has experienced significant growth, driven by innovations such as single-use technologies, advanced cell lines, and state-of-the-art bioreactors. The need to reduce costs, improve speed and efficiency, and scale production effectively has been a major catalyst for progress in bioprocessing.

PRIMARY FOCUS AREAS

• Manufacturing technologies for cell and gene therapy
• Tissue engineering
• Biopharmaceutical manufacturing

Download white paper

trends and engineering challenges in cell culture manufacturing.

Explore the full details of the latest advancements in biotech and bioprocessing, including the challenges and opportunities shaping the future of cell culture, gene therapies, and biopharmaceutical manufacturing. Download the white paper to understand the cutting-edge technologies that will drive the industry forward.

integrating advanced technologies

the importance of cell cultures in addressing healthcare challenges.

Cell cultures play a pivotal role in addressing future healthcare challenges. For instance, cell therapies—where cells are used as treatments—demand the cultivation of high-quality cells. Similarly, controlled and reproducible cell cultivation is essential for other applications, including Lab-on-Chip systems, Organ-on-Chip platforms, and vaccine and viral vector production. Automating cell culture processes can not only standardize product quality but also significantly reduce personnel costs and increase yield. Achieving this requires the integration of advanced technologies, such as cutting-edge sensors, to monitor and control production processes with precision.

biovitronix_v001 (00200)
more precise control

next-generation cell culture equipment development.

The Dutch Growth Fund Consortium NXTGEN Hightech Biomed05 aims to develop next-generation cell culture equipment by leveraging innovative sensor technologies, automation, and microfluidic integration. This initiative seeks to enable more precise control over cell culture processes, resulting in superior-quality cell and cell-derived products. The consortium brings together diverse stakeholders from across the value chain—including CDMOs, cell therapy developers, and technology and materials providers—who collaborate to identify unmet needs and anticipate industry and regulatory requirements.

shutterstock_1368438578

"make bioprocessing faster, more scalable, and more reliable."

A central theme emerging from the workshop was the pressing need for greater automation in closed-loop cell culture systems. Key technological advancements critical for optimizing processes, achieving scalability, and reducing manufacturing costs include real-time monitoring through in-line sensors and the application of artificial intelligence for process control. These innovations aim to make bioprocessing faster, more scalable, and more reliable.